• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Cell stress sensors ATF4 and ATF6 steer how lung cancer cells cope with glucose starvation

by
October 28, 2026
in Cancer, Health
Reading Time: 3 mins read
0
Cell stress sensors ATF4 and ATF6 steer how lung cancer cells cope with glucose starvation

Cell stress sensors ATF4 and ATF6 steer how lung cancer cells cope with glucose starvation

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Lung cancer cells facing a shortage of glucose do not simply shut down. According to a new open-access study published in Cancer & Metabolism on 12 October 2026, two stress-activated transcription factors, ATF4 and ATF6, coordinate the transcriptional and metabolic changes that non-small cell lung carcinoma (NSCLC) cells deploy when their sugar supply is cut off.

Tumours often outgrow their local blood vessels, leaving pockets of tissue starved of oxygen and nutrients. The researchers, led by Mabel Cruz-Rodríguez and senior author Cristina Muñoz-Pinedo, set out to map how cells respond transcriptionally to one of those shortages: a lack of glucose.

To do this, the team used RNA sequencing of A549 lung cancer cells kept without glucose, identifying changes in individual genes and in Reactome pathways through gene-set-enrichment analysis. Bioinformatic inference then pointed to ATF4 and ATF6 as the most relevant transcription factors, which the group went on to test by silencing them with siRNA in several NSCLC cell lines.

The sequencing revealed a striking pattern. Multiple pathways related to DNA replication and the cell cycle were downregulated when glucose was withdrawn, while the single most strongly upregulated transcriptional pathway was the Unfolded Protein Response, or UPR, a stress programme previously shown to help cells adapt to proteotoxic and endoplasmic reticulum stress.

Glucose shortage robustly activated all three branches of the UPR across several NSCLC cell lines, the authors report. The evidence included accumulation of ATF4, splicing of XBP1 mRNA, and cleavage of ATF6. In a network analysis, ATF6 and ATF4 emerged as the transcription factors with the highest scores.

The influence of these two factors extended deep into metabolism. Silencing ATF4 or ATF6 with siRNA regulated multiple metabolic genes and pathways, including amino acid synthesis and transport, glycosylation and lipid synthesis. ATF4 silencing also affected the transcriptional induction of mitochondrial OXPHOS-associated pathways. Direct metabolite measurements showed that ATF4 regulates amino acid and citrate levels during glucose deprivation.

Perhaps the most unexpected finding concerns cell fate. Rather than promoting survival, ATF4 contributed to cell death in glucose-starved cells, with only a limited contribution from its target DR5/TRAILR2. Silencing CHOP, DR4 or NOXA did not affect cell death in glucose-starved A549 cells, and silencing or inhibiting other UPR factors, including ATF6 and IRE1/XBP1s, individually or in combination, likewise did not impact survival under glucose deprivation.

The study also uncovered a role for the stress pathway in controlling mTORC1, a central growth-regulating signalling complex. The absence of ATF4, or of its target sestrin 2, prevented the inactivation of mTORC1 that normally occurs when glucose is withdrawn. In contrast, reducing ATF6 enhanced the activation of XBP1 and ATF4 but did not regulate mTORC1 inactivation, indicating that the two transcription factors act through partly separate mechanisms.

The authors conclude that the Unfolded Protein Response is activated upon glucose deprivation and that some of its transcription factors control both the transcriptional and the metabolic responses to glucose shortage. Because the work was carried out in lung cancer cell lines, the findings describe mechanisms observed in cultured cells rather than outcomes in patients. The article was released early as a peer-reviewed, citable accepted manuscript, and the final version of record will replace it after further edits.

Subject of Research: Transcriptional and metabolic responses to glucose deprivation in non-small cell lung carcinoma cells

Article Title: ATF4 and ATF6 orchestrate transcriptional responses to glucose deprivation in NSCLC

Article References: Cruz-Rodríguez, M., Collado-Rodríguez, L., Favaro, F., Hijazo-Pechero, S., Püschel, F., Both, D., Palau-Gallinat, D., Plans-Marin, S., Jiménez-Hernández, F., Tang, M., Moreno-Caceres, J., Chevet, E., Nadal, E., & Muñoz-Pinedo, C. (2026). ATF4 and ATF6 orchestrate transcriptional responses to glucose deprivation in NSCLC. Cancer & Metabolism. https://doi.org/10.1186/s40170-026-00461-2

Image Credits: AI Generated

DOI: 10.1186/s40170-026-00461-2

Keywords: ATF4, ATF6, glucose deprivation, unfolded protein response, NSCLC, mTORC1, metabolism, XBP1, cell death, RNA sequencing, lung cancer, orchestrate

News Source: Nathaniel Bowman. (October 28, 2026). Cell stress sensors ATF4 and ATF6 steer how lung cancer cells cope with glucose starvation. Scienmag.

Tags: ATF4ATF6Cell Deathglucose deprivationlung cancermetabolismmTORC1NSCLCorchestrateRNA sequencingunfolded protein responseXBP1
Share12Tweet7Share2ShareShareShare1

Related Posts

AI pathology scoring flags longer survival on pembrolizumab in metastatic triple-negative breast cancer

AI pathology scoring flags longer survival on pembrolizumab in metastatic triple-negative breast cancer

October 28, 2026
From Nanoemulsion-Templated Drug Nanoparticles to Machine Learning Property Prediction: The Research Path of Lucas Attia

From Nanoemulsion-Templated Drug Nanoparticles to Machine Learning Property Prediction: The Research Path of Lucas Attia

October 28, 2026

MCV Fails to Reliably Separate Sickle Cell and Thalassemia in Western Kenya Study

October 28, 2026

Eight weeks of vestibular training improves balance and sensory reweighting in older women

October 28, 2026

POPULAR NEWS

  • How an industrial apparel brand stitches narrative into fabric, thread and label

    How an industrial apparel brand stitches narrative into fabric, thread and label

    29 shares
    Share 12 Tweet 7
  • New Open-Access Journal Biomedical Materials Science Launches to Link Materials Innovation with Patient Care

    29 shares
    Share 12 Tweet 7
  • Berberine Eases Diabetic Kidney Damage by Tuning a Renal Sugar-Transport Switch

    29 shares
    Share 12 Tweet 7
  • Palmitoylation Enzyme ZDHHC5 Emerges as Driver of Neutrophil Inflammation in COPD

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AI pathology scoring flags longer survival on pembrolizumab in metastatic triple-negative breast cancer

New method reads sequencing errors directly from overlapping reads to spot rare mutations

From Nanoemulsion-Templated Drug Nanoparticles to Machine Learning Property Prediction: The Research Path of Lucas Attia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.